News

After more promising long-term data, Apellis announced plans to seek regulatory approval. An investigator explains what value it could bring to patients.

The use and legalization of cannabis products has been increasing in the US for a variety of medical concerns. Investigators aim to better understand the risks and benefits of owning a medical marijuana card.

Similar pediatric postoperative mortality rates were observed in Black patients in the highest socioeconomic category and White patients in the lowest socioeconomic category.

Deep learning analyses of photographic images and other test results in clinical trials may reduce cost and improve the consistency and accuracy of end point assessments.

Investigators proposed limitations to epoxy chemicals in workplace environments, as a substantial number of patients reacted to the epoxy hardener compounds featured in the study.

Upadacitinib is now approved for ulcerative colitis, atopic dermatitis, and psoriatic arthritis.

Phase 3 data show the C3 inhibitors' sustained benefit for the common form of vision loss. A primary author explains the significance of the new findings.

AI-based screening for ROP may be more cost-effective than traditional screening modalities, but depends significantly on the added cost of AI.

The hope is society learns some of the lessons from the Cold War to better help patients with mental health concerns.

The decision represents the first ever upadacitinib for a gastroenterological disease.

Rhythm Pharmaceuticals shares data from long-term extension study of setmelanotide in Bardet-Biedl Syndrome.

Investigators believe these results may aid shared decision-making between clinicians and patients.

Social media has had an influence on the mental health toll the war in the Ukraine is having.

Approximately 60% of patients with ulcerative colitis treated with guselkumab achieved clinical remission.

Apixaban prescription beyond 90 days showed no difference in hospitalization risk for major bleeding.

New data show the highest quintile of census-reported parental income is far more represented among future physicians than lower income levels, regardless of race.

Internalized skin bias also appeared to mediate the associations of depression and anxiety related to health-related quality of life.

The phase 3 trial was stopped following a formal interim assessment that met pre specified criteria for positive efficacy in patients with chronic kidney disease.

ChristianaCare’s Gene Editing Institute experts join the podcast to discuss the latest developments in gene editing.

An analysis of the EUROSTAD study found that the median duration of treatment with the biologic was 14 months.

The inhaler is approved for 2 strengths, 160/4.5 mcg/actuation and 80/4.5 mcg/actuation.

Novartis announces promising results from research evaluating the safety and efficacy of Zolgensma.

Children with unconfirmed PALs have prolonged hospital stays, higher rates of adverse events, and more infections due to Clostridium difficile and vancomycin-resistant Enterococcus.

The recurrent CDI cohort were nearly 10 times likelier to suffer from a CDI-associated death than the primary CDI cohort.

Data show LNCSBs as a substitute for sugar-sweetened beverages were associated with reduced body weight, BMI, percentage of body fat, and intrahepatocellular lipid.

A new post-hoc analyses for the sodium oxybate FT218 found that the therapy improved daytime sleepiness, sleep quality, and refreshing nature of sleep in patients with narcolepsy.

USPSTF experts noted a need for research into the benefits and harms of screening adults and adolescents without signs or symptoms.

Data show the absolute risk reductions of treatment with statins in terms of all-cause mortality, myocardial infarction, and stroke are modest compared with the relative risk reductions.